C
Clarient
Provides oncology testing and diagnostic services in the united states
About Clarient
Clarient Inc. is a leading provider of cancer genetic testing and information services, specializing in offering one of the most comprehensive oncology-focused testing menus globally. The company serves physicians by providing advanced diagnostic tools to help in the diagnosis and treatment of cancer. Additionally, Clarient Inc. operates a Pharma Services division that caters to pharmaceutical clients involved in clinical trials and drug development. Headquartered in Fort Myers, Florida, the company is expanding its capabilities with a new state-of-the-art oncology laboratory and global headquarters. Clarient Inc. generates revenue through its Clinical Services and Pharma Services divisions, with the former seeing a 7.9% increase in revenue to $93.0 million in the second quarter of 2020. The company collaborates with other industry leaders, such as QIAGEN, to offer specialized diagnostic tests, including those for advanced breast cancer patients. Clarient Inc. operates in the healthcare and biotechnology markets, focusing on precision medicine and personalized cancer care.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1993
- Headquarters
- Aliso Viejo, United States
- Open positions
- None listed
- Dealroom signal
- 21.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2c
- Investment activity
- 1 company, latest Dec 2009
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Oct 2010 | $587M | $587M | GE Healthcare | — |
| EARLY VCOther financing | Dec 2009 | $11M | $44M | Undisclosed | — |
Growth signals
Latest recorded traffic for Clarient is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Oak Investment
Other known investors1 additional known investor
GE Healthcare
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Clarient on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Clarient’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.